Comprehensive HIV Prevention Package for MSM in Port Elizabeth
NCT02449733 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101
Last updated 2017-07-06
Summary
The purpose of this study is to evaluate the acceptability and uptake of a combination package of biomedical, behavioral and community-level HIV prevention interventions and services for men who have sex with men (MSM) in South Africa.
Conditions
Interventions
- BEHAVIORAL
-
Condom choices
Men will receive the condom package that includes an assortment of styles, sizes, features and colors at their baseline visit, and will be able to get more condoms for free at any time after that visit by coming to a study clinic during clinic hours, or during a scheduled study visit.
- BEHAVIORAL
-
Condom-compatible lubricant choices
Men will receive condom-compatible lubricant that will include different types of lubricant (e.g., silicone-based) and different packaging (individual sachets or flat, discreet packages) at their baseline study visit, and participants will be able to access enhanced condom-compatible lubricant at any time after that visit by coming to a study clinic during clinic hours, or during a scheduled study visit.
- BEHAVIORAL
-
Couples HIV counseling and testing (CVCT)
Participants will be invited to schedule couples voluntary HIV counseling and testing (CVCT) appointments with a clinic counselor at any point after they complete their baseline study visit.
- DRUG
-
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
FTC/TDF is a once daily oral tablet taken with or without food. The tablet includes 200 mg of emtricitabine (FTC) and 300 mg of tenofovir disoproxil fumarate (TDF). For men who meet eligibility criteria, Pre-exposure prophylaxis (PrEP) with Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) will be made available beginning one month into the study. Men who express interest and meet eligibility criteria at their baseline visit can initiate PrEP at 1 month if they test negative for HIV. For men with extenuating circumstances, whose risk profile changes, of those who become more comfortable with the PrEP intervention through enrollment in the study, PrEP will be available to initiate at the 4 month visit.
- OTHER
-
HIV Testing
Rapid HIV testing at multiple time points
- OTHER
-
Linkage to care
Men will be linked to needed services including HIV care and treatment for positives identified at baseline or during the study, including antiretroviral medications, and mental health services. At the end of their baseline visit, participants will receive service referral handouts for HIV care and treatment, mental health services, and other resources, as appropriate. Men who test positive for sexually transmitted infections (STIs )will be treated at the clinic site.
- PROCEDURE
-
Post-exposure prophylaxis (PEP)
Two to three antiretroviral medicines as soon as possible (recommended is emtricitabine/tenofovir disoproxil fumarate plus either raltegravir or dolutegravir), but no more than 72 hours (3 days) after one may have been exposed to HIV, to try to reduce the chance of becoming HIV-positive. They must be taken for 28 days.
- BEHAVIORAL
-
Risk-reduction counseling
Risk-reduction counseling will be provided to all men at baseline and additionally at 3, 6, and 12 month visits, with an additional counseling session for men on PrEP at their initiation visit (either month 1 or 4), their 1-month follow-up visit (either month 2 or 5) and at their 9 month visit. Risk reduction counseling will be client-centered counseling, according to CDC's Fundamentals of HIV Prevention Counseling protocol.
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Patrick S Sulivan, DVM, PhD · Rollins School of Public Health
-
A.D. McNaghten, PhD, MHSA · Rollins School of Public Health
-
Stefan Baral, MD, MPH, CCFP · Johns Hopkins Bloomberg School of Public Health
-
Nancy Phaswanamafuya, PhD · Human Sciences Research Council
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2016-10-31
- Completion
- 2017-03-31
Countries
- South Africa
Study Locations
More Related Trials
-
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
NCT02663219 ·Status: COMPLETED ·Phase: NA
-
PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color
NCT02367807 ·Status: COMPLETED
-
Getting to Zero Among HHI MSM in the American South
NCT05075967 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Behavioral and Biomedical HIV Prevention Interventions for Thai Men Who Have Sex With Men
NCT02161289 ·Status: COMPLETED
-
Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine
NCT00291512 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples
NCT00644163 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a New HIV Prevention Intervention for Black Bisexually-active Men
NCT01347164 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Consent and Survey Procedures for Young MSM in Web-based HIV Prevention
NCT02139566 ·Status: COMPLETED ·Phase: NA
-
Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders
NCT05934305 ·Status: RECRUITING ·Phase: NA
-
HIV Prevention for HIV-Negative Men Via Reduction of Social Anxiety
NCT02045225 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility of HIV Prevention Cohort Studies Among Men Who Have Sex With Men in Sub-Saharan Africa
NCT03201510 ·Status: COMPLETED
-
Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
NCT05813964 ·Status: RECRUITING ·Phase: PHASE3
-
Factors Affecting the Intention to Take nPEP Among Thai MSM
NCT02107911 ·Status: COMPLETED
-
MHealth Intervention of HIV and STDs Partner Notification for MSM
NCT04349748 ·Status: UNKNOWN ·Phase: NA
-
Risk Taking Behaviour in MSM and the Denial of Sexually Transmitted Diseases and HIV
NCT01279005 ·Status: UNKNOWN
-
Implementing a Comprehensive Prevention of Mother-to-Child Transmission of HIV Program for South African Couples
NCT02085356 ·Status: COMPLETED ·Phase: NA
-
Understanding Substance Use and Incident HIV/STI Among Young Black MSM
NCT02503618 ·Status: COMPLETED
-
Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men
NCT00951249 ·Status: COMPLETED ·Phase: NA
-
HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
NCT01808352 ·Status: COMPLETED
-
An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South
NCT05087680 ·Status: RECRUITING ·Phase: NA
-
Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse
NCT03577301 ·Status: COMPLETED ·Phase: NA
-
Optimizing PrEP Adherence for Young Men Who Have Sex With Men
NCT03493555 ·Status: COMPLETED ·Phase: NA
-
Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing
NCT00968188 ·Status: COMPLETED ·Phase: NA
-
Improving Survey Procedures for Young Men Who Have Sex With Men in Web-based HIV Prevention: Retention Study
NCT02424643 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)
NCT02067039 ·Status: COMPLETED ·Phase: NA